LAURA ARMIJO: Open Payments
NPI 1134986151 · RIO RANCHO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 24 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $294 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Genmab U.S., Inc. | 3 | $70 |
| Janssen Biotech, Inc. | 3 | $61 |
| Daiichi Sankyo Inc. | 2 | $47 |
| EMD Serono, Inc. | 2 | $43 |
| SOBI, INC | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Aveo Pharmaceuticals, Inc. | 1 | $25 |
| Eisai Inc. | 1 | $23 |
| Exelixis Inc. | 1 | $21 |
Products named: Enhertu, Tivdak, Doptelet, RYBREVANT, PLUVICTO, FOTIVDA, Vanflyta, Lenvima.
Industry payments across NM — which companies pay providers there.
